2018年11月29日,北京华通华康公益基金会(Beijing Huatong Guokang Foundation,简称“BHGF”)与澳大利亚医学促进会(Australian Medical Association,简称“AMA”)签署合作备忘录,BHGF陈冉理事长、AMA执行董事Paul Boyatzis先生、赴澳大利亚卫生学术体系交流项目代表团共同出席了签字仪式。双方将共同努力搭建中澳医学交流合作平台,在人才培养、科研及学术交流等方面的展开合作。
澳大利亚医学促进会(AMA)是澳大利亚医生和医学生的专业协会。其总部位于澳大利亚首都辖区巴顿,在澳大利亚各州和地区设立分支机构。AMA拥有一系列代表性委员会,致力于与成员合作,促进和保护医生的利益。AMA机制包括:与各国政府合作,增加向澳大利亚公民提供世界的医疗服务;跟踪和报告政府在健康方面的行为;对可能损害患者利益的政策提出挑战;就健康问题提出共鸣和权威的专家医学评论;通过建立广泛的专家资源回应健康辩题;调试和开展健康问题研究。
澳大利亚医学促进会(AMA)执行董事Paul Boyatzis发言
Mr. Paul Boyatzis, Executive Director of Australian Medical Association (AMA) making his speech
北京华通国康公益基金会(BHGF)陈冉理事长发言
Chairman Chen Ran of Beijing Huatong Guokang Foundation (BHGF) making her speech
双方签署合作备忘录
Both sides signing the Memorandum
合作备忘录签署仪式
The signing ceremony of Memorandum
合影
Group photo
AMA and BHGF Signing Memorandum of Cooperation
On November 29th, 2018, Beijing Huatong Guokang Foundation ("BHGF") signed a memorandum of cooperation with the Australian Medical Association ("AMA"). Chairman Chen Ran of BHGF, Mr. Paul Boyatzis, Executive Director of AMA, and the delegation of 2018 Australian Healthcare Academic Exchange Program attended the signing ceremony. The two sides will work together to build China-Australian medical exchange and cooperation platform and cooperate in personnel training, scientific research and academic exchanges.
AMA has a range of representative committees, which is dedicated to working with members to promote and protect the interests of doctors. The AMA mechanism includes: working with governments to increase the provision of world-class medical services to Australian citizens; tracking and reporting on government health practices; challenging policies that may harm the interests of patients; putting forward resonance and authoritative expert medical reviews on health issues; responding to health debates by establishing a wide range of expert resources; commissioning and conducting research on health issues.